Cargando…
Implementation of a model integrating primary and oncology pharmacists' care for patients taking oral anticancer agents (OAA)
Improvements in chronic myeloid leukemia (CML), chronic lymphocytic leukemia (CLL), and multiple myeloma (MM) treatment options have increased the 5-year survival rates for patients with these hematologic malignancies. In addition to cancer management, these patients may need help to manage multiple...
Autores principales: | Farris, Karen B., Cadwallader, Tiffany, Farley, Joel, Gatwood, Katie, Mackler, Emily, Gatwood, Justin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9358049/ https://www.ncbi.nlm.nih.gov/pubmed/35957656 http://dx.doi.org/10.1016/j.rcsop.2022.100163 |
Ejemplares similares
-
THE AGING NETWORK AND THE OAA REAUTHORIZATION
por: Gotwals, Amy
Publicado: (2019) -
OAA AND THE GOAL TO END MALNUTRITION
por: Blancato, Robert
Publicado: (2019) -
Medication Adherence, Health Care Utilization, and Costs Among Patients Initiating Oral Oncolytics for Multiple Myeloma or Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
por: Dashputre, Ankur A., et al.
Publicado: (2020) -
Barriers and facilitators associated with implementing interventions to support oral anticancer agent adherence in academic and community cancer center settings
por: Muluneh, Benyam, et al.
Publicado: (2023) -
Advancing States Through the OAA Reauthorization
por: Terzaghi, Damon
Publicado: (2020)